Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)

COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the curr...

Full description

Bibliographic Details
Main Authors: Suzanne Norris, Philip O'Gorman
Format: Article
Language:English
Published: BMJ Publishing Group 2021-09-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/8/1/e000568.full
id doaj-0fd01f16e64b431db36980535c4f2e66
record_format Article
spelling doaj-0fd01f16e64b431db36980535c4f2e662021-10-04T12:30:03ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742021-09-018110.1136/bmjgast-2020-000568Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)Suzanne Norris0Philip O'Gorman14 Department of Hepatology, St. James`s Hospital, Dublin, IrelandSchool of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, IrelandCOVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to suppress the spread of COVID-19 on exercise and physical activity participation in patients with NAFLD. The future of exercise prescription and the potential use of digital technology in addressing NAFLD healthcare needs in the COVID-19 era are also explored.https://bmjopengastro.bmj.com/content/8/1/e000568.full
collection DOAJ
language English
format Article
sources DOAJ
author Suzanne Norris
Philip O'Gorman
spellingShingle Suzanne Norris
Philip O'Gorman
Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
BMJ Open Gastroenterology
author_facet Suzanne Norris
Philip O'Gorman
author_sort Suzanne Norris
title Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title_short Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title_full Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title_fullStr Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title_full_unstemmed Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
title_sort exercising in the covid-19 era: implications in non-alcoholic fatty liver disease (nafld)
publisher BMJ Publishing Group
series BMJ Open Gastroenterology
issn 2054-4774
publishDate 2021-09-01
description COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to suppress the spread of COVID-19 on exercise and physical activity participation in patients with NAFLD. The future of exercise prescription and the potential use of digital technology in addressing NAFLD healthcare needs in the COVID-19 era are also explored.
url https://bmjopengastro.bmj.com/content/8/1/e000568.full
work_keys_str_mv AT suzannenorris exercisinginthecovid19eraimplicationsinnonalcoholicfattyliverdiseasenafld
AT philipogorman exercisinginthecovid19eraimplicationsinnonalcoholicfattyliverdiseasenafld
_version_ 1716844100608589824